Product Code: ETC6185317 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The market for minimally invasive glaucoma surgery (MIGS) devices in Australia is expanding due to the increasing prevalence of glaucoma, particularly in older populations. MIGS procedures are less invasive than traditional glaucoma surgeries, leading to faster recovery times and fewer complications. As awareness of the effectiveness of MIGS techniques grows among both patients and ophthalmologists, the demand for these devices is increasing. Additionally, with the Australia healthcare system increasingly focused on reducing the burden of chronic diseases, the use of MIGS devices is expected to rise in the coming years.
The Australia minimally invasive glaucoma surgery (MIGS) devices market is experiencing growth, driven by the increasing incidence of glaucoma and the demand for safer and more efficient treatment options. MIGS procedures, which require smaller incisions and offer quicker recovery times compared to traditional surgeries, are gaining popularity among patients. The market is benefiting from technological advancements that allow for better control of intraocular pressure and reduced risk of complications. The demand for MIGS devices is also supported by the aging population, as glaucoma is more common in older adults.
The market for minimally invasive glaucoma surgery devices in Australia is facing challenges related to the increasing demand for these devices, which strains the supply chain. While these devices offer significant advantages over traditional surgical methods, including faster recovery times, their high cost can deter widespread adoption. Additionally, there is a need for ongoing education for both patients and healthcare providers on the benefits and proper use of these devices. Regulatory approval processes and the need for clinical evidence to support efficacy also present obstacles to market growth.
The Australia Minimally Invasive Glaucoma Surgery Devices market offers strong investment potential as it caters to the growing prevalence of glaucoma among aging populations. Minimally invasive glaucoma surgeries, such as microstent implantations, are gaining popularity due to their ability to reduce the need for traditional, more invasive surgery. Investment in developing next-generation devices that provide better outcomes, fewer complications, and faster recovery is an area of interest. Additionally, focusing on innovations that integrate advanced monitoring and diagnostic tools can enhance treatment efficiency and provide a competitive edge in the market.
The Australia government actively supports the use of minimally invasive glaucoma surgery (MIGS) devices as part of a broader effort to improve ophthalmic care. The TGA regulates these devices, ensuring their safety and efficacy before they are allowed for use in the Australia healthcare system. Medicare covers certain glaucoma procedures, making MIGS devices more accessible to patients. The governments focus on reducing healthcare costs through the adoption of innovative medical technologies has led to increased use of MIGS devices, as they offer effective treatment with reduced recovery times compared to traditional methods.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Minimally Invasive Glaucoma Surgery Devices Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Minimally Invasive Glaucoma Surgery Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Minimally Invasive Glaucoma Surgery Devices Market - Industry Life Cycle |
3.4 Australia Minimally Invasive Glaucoma Surgery Devices Market - Porter's Five Forces |
3.5 Australia Minimally Invasive Glaucoma Surgery Devices Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Australia Minimally Invasive Glaucoma Surgery Devices Market Revenues & Volume Share, By Surgery Method, 2021 & 2031F |
3.7 Australia Minimally Invasive Glaucoma Surgery Devices Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Australia Minimally Invasive Glaucoma Surgery Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Minimally Invasive Glaucoma Surgery Devices Market Trends |
6 Australia Minimally Invasive Glaucoma Surgery Devices Market, By Types |
6.1 Australia Minimally Invasive Glaucoma Surgery Devices Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Australia Minimally Invasive Glaucoma Surgery Devices Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Australia Minimally Invasive Glaucoma Surgery Devices Market Revenues & Volume, By Valves, 2021- 2031F |
6.1.4 Australia Minimally Invasive Glaucoma Surgery Devices Market Revenues & Volume, By Glaucoma Drainage Implant, 2021- 2031F |
6.1.5 Australia Minimally Invasive Glaucoma Surgery Devices Market Revenues & Volume, By Glaucoma Tube Shunts, 2021- 2031F |
6.1.6 Australia Minimally Invasive Glaucoma Surgery Devices Market Revenues & Volume, By Stents, 2021- 2031F |
6.1.7 Australia Minimally Invasive Glaucoma Surgery Devices Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Minimally Invasive Glaucoma Surgery Devices Market, By Surgery Method |
6.2.1 Overview and Analysis |
6.2.2 Australia Minimally Invasive Glaucoma Surgery Devices Market Revenues & Volume, By Trabecular Meshwork Bypass, 2021- 2031F |
6.2.3 Australia Minimally Invasive Glaucoma Surgery Devices Market Revenues & Volume, By Stent Placement, 2021- 2031F |
6.2.4 Australia Minimally Invasive Glaucoma Surgery Devices Market Revenues & Volume, By Tissue Excision, 2021- 2031F |
6.2.5 Australia Minimally Invasive Glaucoma Surgery Devices Market Revenues & Volume, By Suprachoroidal Space Implants, 2021- 2031F |
6.3 Australia Minimally Invasive Glaucoma Surgery Devices Market, By End-use |
6.3.1 Overview and Analysis |
6.3.2 Australia Minimally Invasive Glaucoma Surgery Devices Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Australia Minimally Invasive Glaucoma Surgery Devices Market Revenues & Volume, By Ophthalmic Clinics, 2021- 2031F |
6.3.4 Australia Minimally Invasive Glaucoma Surgery Devices Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Minimally Invasive Glaucoma Surgery Devices Market Import-Export Trade Statistics |
7.1 Australia Minimally Invasive Glaucoma Surgery Devices Market Export to Major Countries |
7.2 Australia Minimally Invasive Glaucoma Surgery Devices Market Imports from Major Countries |
8 Australia Minimally Invasive Glaucoma Surgery Devices Market Key Performance Indicators |
9 Australia Minimally Invasive Glaucoma Surgery Devices Market - Opportunity Assessment |
9.1 Australia Minimally Invasive Glaucoma Surgery Devices Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Australia Minimally Invasive Glaucoma Surgery Devices Market Opportunity Assessment, By Surgery Method, 2021 & 2031F |
9.3 Australia Minimally Invasive Glaucoma Surgery Devices Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Australia Minimally Invasive Glaucoma Surgery Devices Market - Competitive Landscape |
10.1 Australia Minimally Invasive Glaucoma Surgery Devices Market Revenue Share, By Companies, 2024 |
10.2 Australia Minimally Invasive Glaucoma Surgery Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |